510(k) K212721
K212721 is an FDA 510(k) premarket notification submitted by Biocomposites, Ltd. for the device "Genex Bone Graft Substitute". The FDA issued a decision of Substantially Equivalent on February 4, 2022. The device falls under product code MQV (Filler, Bone Void, Calcium Compound), a Class II device regulated under 21 CFR 888.3045. Biocomposites, Ltd. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- February 4, 2022
- Date Received
- August 27, 2021
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Filler, Bone Void, Calcium Compound
- Device Class
- Class II
- Regulation Number
- 888.3045
- Review Panel
- OR
- Submission Type